Ronald Kirk Huntsman - Net Worth and Insider Trading
Ronald Kirk Huntsman Net Worth
The estimated net worth of Ronald Kirk Huntsman is at least $222,836 dollars as of 2024-11-13. Ronald Kirk Huntsman is the CEO of Vivos Therapeutics Inc and owns about 73,061 shares of Vivos Therapeutics Inc (VVOS) stock worth over $222,836. Details can be seen in Ronald Kirk Huntsman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ronald Kirk Huntsman has not made any transactions after 2023-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ronald Kirk Huntsman
Ronald Kirk Huntsman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald Kirk Huntsman owns 1 companies in total, including Vivos Therapeutics Inc (VVOS) .
Click here to see the complete history of Ronald Kirk Huntsman’s form 4 insider trades.
Insider Ownership Summary of Ronald Kirk Huntsman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VVOS | Vivos Therapeutics Inc | 2023-06-20 | director & 10 percent owner & Chairman & CEO |
Ronald Kirk Huntsman Latest Holdings Summary
Ronald Kirk Huntsman currently owns a total of 1 stock. Ronald Kirk Huntsman owns 73,061 shares of Vivos Therapeutics Inc (VVOS) as of June 20, 2023, with a value of $222,836.
Latest Holdings of Ronald Kirk Huntsman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VVOS | Vivos Therapeutics Inc | 2023-06-20 | 73,061 | 3.05 | 222,836 |
Holding Weightings of Ronald Kirk Huntsman
Ronald Kirk Huntsman Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald Kirk Huntsman has made a total of 10 transactions in Vivos Therapeutics Inc (VVOS) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Vivos Therapeutics Inc is the acquisition of 560 shares on June 20, 2023, which cost Ronald Kirk Huntsman around $7,420.
Insider Trading History of Ronald Kirk Huntsman
- 1
Ronald Kirk Huntsman Trading Performance
GuruFocus tracks the stock performance after each of Ronald Kirk Huntsman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald Kirk Huntsman is -28.73%. GuruFocus also compares Ronald Kirk Huntsman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald Kirk Huntsman within 3 months outperforms 0 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ronald Kirk Huntsman's insider trading performs compared to the benchmark.
Performance of Ronald Kirk Huntsman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.66 | | | | | |
| Relative Return to S&P 500(%) | 0.61 | | | | | |
Ronald Kirk Huntsman Ownership Network
Ownership Network List of Ronald Kirk Huntsman
Ownership Network Relation of Ronald Kirk Huntsman
Ronald Kirk Huntsman Owned Company Details
What does Vivos Therapeutics Inc do?
Who are the key executives at Vivos Therapeutics Inc?
Ronald Kirk Huntsman is the director & 10 percent owner & Chairman & CEO of Vivos Therapeutics Inc. Other key executives at Vivos Therapeutics Inc include Chief Financial Officer Bradford K. Amman , and director & 10 percent owner & Chief Medical Officer Gurdev Dave Singh .
Vivos Therapeutics Inc (VVOS) Insider Trades Summary
Over the past 18 months, Ronald Kirk Huntsman made 3 insider transaction in Vivos Therapeutics Inc (VVOS) with a net purchase of 39,021.
In summary, during the past 3 months, insiders sold 0 shares of Vivos Therapeutics Inc (VVOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vivos Therapeutics Inc (VVOS) were sold and 1,561 shares were bought by its insiders, resulting in a net purchase of 1,561 shares.
Vivos Therapeutics Inc (VVOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vivos Therapeutics Inc Insider Transactions
Ronald Kirk Huntsman Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald Kirk Huntsman. You might contact Ronald Kirk Huntsman via mailing address: 9137 Ridgeline Boulevard, Suite 135, Highlands Ranch Co 80129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
